Kentley Insights’ 2025 Residential Disability, Mental Health, & Substance Abuse Facilities Global Market Size & Growth Report covers revenue, growth, and regional share across 4 global regions, 22 subregions, and 195 countries. Historical data is from 2013 through 2024, with forecasts for 2025 and 2 ...

Kentley Insights’ 2025 Outpatient Mental Health and Substance Abuse Centers Global Market Size & Growth Report covers revenue, growth, and regional share across 4 global regions, 22 subregions, and 195 countries. Historical data is from 2013 through 2024, with forecasts for 2025 and 2029. The histor ...

Kentley Insights’ 2025 Psychiatry Global Market Size & Growth Report covers revenue, growth, and regional share across 4 global regions, 22 subregions, and 195 countries. Historical data is from 2013 through 2024, with forecasts for 2025 and 2029. The historical data utilizes in-depth survey results ...

Kentley Insights’ 2025 Residential Mental Health and Substance Abuse Facilities Global Market Size & Growth Report covers revenue, growth, and regional share across 4 global regions, 22 subregions, and 195 countries. Historical data is from 2013 through 2024, with forecasts for 2025 and 2029. The hi ...

Companies in this industry provide outpatient and residential care and treatment for individuals with mental health and substance abuse illnesses. Major companies include Acadia Healthcare, Hazelden Betty Ford Foundation, and Corewell Health (all based in the US), along with the Centre for Addiction ...

The 78-page 2025 Outpatient Mental Health and Substance Abuse Centers Market Research Report is one of the most comprehensive and in-depth assessments of the industry in the United States with over 100+ data sets covering 2016-2029. This Kentley Insights report is full of industry insights including ...

The 78-page 2025 Residential Disability, Mental Health, & Substance Abuse Facilities Market Research Report is one of the most comprehensive and in-depth assessments of the industry in the United States with over 100+ data sets covering 2016-2029. This Kentley Insights report is full of industry ins ...

The 78-page 2025 Residential Mental Health and Substance Abuse Facilities Market Research Report is one of the most comprehensive and in-depth assessments of the industry in the United States with over 100+ data sets covering 2016-2029. This Kentley Insights report is full of industry insights inclu ...

The Thai dairy sector is entering a period of transformation, shaped by regulatory pressures and shifting consumer priorities. The Thai Food and Drug Administration (FDA) has tightened the requirements for products qualifying for the “Healthier Choice” logo, with more stringent thresholds on sugar a ...

Sleep aids in Switzerland is set to register a robust performance in 2025, driven by the widespread prevalence of insomnia and other sleep disturbances among adults. According to the Swiss Federal Statistical Office (FSO), more than 30% of consumers suffer from sleep issues. This is related to many ...

Sales of sleep aids have continued to decline in value and volume terms in 2025. A lack of innovation in pill, gummy, and liquid formats highlights consumer disinterest in self-medicating orally. Instead, there is a growing focus on vitamins and dietary supplements that claim to help promote a good ...

Value sales of sleep aids are set to increase in Norway in 2025. Sleep aids remain one of the more dynamic categories within consumer health; however, growth has slowed following a strong multi-year expansion. Melatonin continues to be the dominant ingredient and has, in the eyes of many consumers, ...

Value sales of sleep aids in the Czech Republic increased modestly in 2025. The category benefited from the rising prevalence of insomnia and milder sleep disturbances, reflecting growing stress and pressure in everyday life. Many Czech consumers are reporting difficulty falling or staying asleep, a ...

Value sales of sleep aids increased in Belgium in 2025, supported by strong volume growth across the category. This upward trend reflects a growing prevalence of sleep-related issues, with more consumers seeking effective solutions to counter rising levels of anxiety, mental stress, and uncertainty. ...

Sales of cough, cold and allergy (hay fever) remedies have increased in current value terms in 2025, on the heels of a weak cough and cold season in 2024 followed by a spike in cases in late January and early February 2025. Combination products remains the largest category and it has also been one o ...

Sleep aids in the United Arab Emirates is projected to continue to register healthy retail volume and current value sales growth over 2025, partly due to the rising population in the market. Growth rates are forecast to be slower than in 2024, as more consumers are turning to alternative solutions, ...

Value sales of sleep aids in Bulgaria increased in 2025. Bulgarians are facing increasingly hectic lives marked by high levels of stress and anxiety. The lingering impact of the pandemic on mental health has been compounded by political instability, inflation, and the rising cost of living. Concerns ...

Retail value sales of sleep aids are set to decline in current terms in Japan in 2025. Volume sales are also expected to continue to fall during the year. Players have made efforts to sustain demand through brand refreshes and public education. A notable example was the full packaging renewal of the ...

Value sales of sleep aids are rising robustly in Mexico in 2025, though growth is showing signs of deceleration. This is in line with subdued consumer spending caused by the country’s challenging economic conditions and a high comparison base after several years of double-digit growth following the ...

Sleep aids is set to deliver strong current value growth in Canada in 2025 following significant gains in the previous year as sleep issues continue to impact many Canadians. Euromonitor’s Voice of the Consumer: Health and Nutrition consumer survey for Canada reported 49.1% of respondents were moder ...

In 2025, sleep aids in Germany is projected to see further growth in retail volume and current value sales over 2025. Growth is being driven by the increasing demand from consumers for traditional herbal remedies and melatonin-based products to address the ongoing sleep issues affecting a significan ...

Retail value sales of sleep aids are expected to increase in current terms in the UK in 2025. This steady rise reflects a growing awareness of the importance of sleep as a cornerstone of overall wellbeing amongst UK consumers. The hybrid working model, now a permanent fixture in many households, has ...

Value sales of sleep aids are rising rapidly in 2025, with significant expansion highly influenced by increasing cases of mental health issues such as depression and anxiety. These conditions have been exacerbated amid economic challenges and an uncertain political landscape, further compromising sl ...

Retail value sales of sleep aids are expected to grow strongly in current terms in South Korea in 2025. The trend in sleep aids has remained more focused on relaxation rather than directly addressing sleep issues. This is largely due to the regulatory stance on melatonin, which is classified as a ph ...

In 2025, sleep aids in China is posting strong value growth, supported by rising consumer awareness and acceptance. International brand entries are helping to boost visibility, while domestic players leverage traditional remedies. Premium formulations and innovative formats are driving higher unit p ...